Skip to main content
Fig. 2 | BMC Neurology

Fig. 2

From: A possible role of low regulatory T cells in anti-acetylcholine receptor antibody positive myasthenia gravis after bone marrow transplantation

Fig. 2

Clinical courses of the present case. VC (in L) and anti-AChR antibody titer (in nmol/L) are shown in a line chart and a bar graph, respectively. Intravenous immunoglobulin was initially administered (0.4 g/kg for 5 days) with only moderate response. Two courses of mPSL pulse treatment (1 g for 2 to 3 days) rather exacerbated MG symptoms. Meanwhile, he was started on pyridostigmine 180 mg/day and tacrolimus 3 mg/day. Finally, he was administered four courses of weekly rituximab 375 mg/m2, and his fatigability and weakness continued to improve steadily without pyridostigmine

Back to article page

BMC Neurology

ISSN: 1471-2377

Contact us